Metastatic Melanoma
Showing NaN - NaN of 22
Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in
Active, not recruiting
- Metastatic Melanoma
- +22 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +24 more
Jan 19, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +20 more
- Ipilimumab
- +3 more
-
Tampa, Florida
- +6 more
Jan 13, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +12 more
- Memantine
- +4 more
-
Tucson, Arizona
- +60 more
Jan 11, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Metastatic Melanoma
- Dabrafenib Mesylate
- +2 more
-
Atlanta, Georgia
- +6 more
Nov 30, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Biospecimen Collection
- +9 more
-
Birmingham, Alabama
- +848 more
Aug 24, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma Trial in United States
Recruiting
- Acral Lentiginous Melanoma
- +6 more
- Binimetinib
- +3 more
-
Birmingham, Alabama
- +309 more
Nov 8, 2021
Advanced Cancer, Metastatic Melanoma, Metastatic NSCLC Trial in Worldwide (LY3214996, Midazolam, Abemaciclib)
Active, not recruiting
- Advanced Cancer
- +3 more
- LY3214996
- +6 more
-
Washington, District of Columbia
- +12 more
Sep 2, 2021
Metastatic Melanoma Trial in Worldwide (MORAb-004 (mAb))
Completed
- Metastatic Melanoma
- MORAb-004 (monoclonal antibody)
-
Scottsdale, Arizona
- +28 more
Aug 6, 2021
Metastatic Melanoma Trial in Worldwide (Lifileucel)
Active, not recruiting
- Metastatic Melanoma
- Lifileucel
-
La Jolla, California
- +56 more
Mar 24, 2021
Metastatic Melanoma Trial in United States (vemurafenib + HD IL-2)
Terminated
- Metastatic Melanoma
- vemurafenib + HD IL-2
-
Tucson, Arizona
- +20 more
Jan 28, 2021
Metastatic Melanoma Trial in Pittsburgh (DC vaccine, Dasatinib)
Completed
- Metastatic Melanoma
- DC vaccine
- Dasatinib
-
Pittsburgh, PennsylvaniaHillman Cancer Center
Aug 12, 2019
Treatment Patterns and Clinical Response in Malignancy
Completed
- Metastatic Renal Cell Carcinoma
- Metastatic Melanoma
-
Tucson, Arizona
- +44 more
Jun 11, 2019
Metastatic Melanoma, Recurrent Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in United States (Aldesleukin, Laboratory
Completed
- Metastatic Melanoma
- +6 more
- Aldesleukin
- +2 more
-
Duarte, California
- +20 more
May 9, 2019
Metastatic Melanoma, Cutaneous Melanoma Trial in Chicago, Pittsburgh (HDI, KW2871)
Completed
- Metastatic Melanoma
- Cutaneous Melanoma
-
Chicago, Illinois
- +1 more
Feb 19, 2018
Melanoma, Metastatic Melanoma Trial in United States (Vemurafenib, Bevacizumab, Cobimetinib)
Terminated
- Melanoma
- Metastatic Melanoma
- Vemurafenib
- +2 more
-
Los Angeles, California
- +13 more
Sep 22, 2017
Metastatic Melanoma Trial in Pittsburgh (Vaccination)
Terminated
- Metastatic Melanoma
- Vaccination
-
Pittsburgh, PennsylvaniaUpmc Upci Hcc
Jul 16, 2017